IP Library Assignment 057568/0984
Patent Assignment
Reel/Frame 057568/0984

Change of Name

Recorded: 2021-09-22 Pages: 7
Assignor
AVI BIOPHARMA, INC.
Executed: 2012-07-11
Assignee
SAREPTA THERAPEUTICS, INC.
215 FIRST STREET, CAMBRIDGE, MASSACHUSETTS, 02142
Covered Properties (6)
Compositions for Enhancing Transport of Molecules into Cells
Patent: 7,468,418 →
Application: 10/836,804 →
Publication: US 2004/0265879
Antisense Antibacterial Method and Compound
Patent: 7,790,694 →
Application: 11/487,009 →
Publication: US 2007/0135333
Antibacterial Antisense Oligonucleotide and Method
Patent: 8,067,571 →
Application: 11/803,107 →
Publication: US 2008/0194463
Peptide Conjugated, Inosine-Substituted Antisense Oligomer Compound and Method
Patent: 8,053,420 →
Application: 12/060,135 →
Publication: US 2008/0182973
Compositions for Enhancing Transport of Molecules into Cells
Patent: 9,572,899 →
Application: 12/265,499 →
Publication: US 2009/0082547
Method of Synthesis of Morpholino Oligomers
Patent: 8,299,206 →
Application: 12/271,036 →
Publication: US 2009/0131632
Related Assignments (6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 16, 2004
From: IVERSEN, PATRICK L.; MOULTON, HONG M.; NELSON, MICHELLE H.; KROEKER, ANDREW D.
To: AVI BIOPHARMA, INC.
Reel/Frame 015678/0760 →
Assignment of Assignor's Interest Feb 26, 2007
From: GELLER, BRUCE L.; IVERSEN, PATRICK L.; TILLEY, LUCAS D.
To: AVI BIOPHARMA, INC.
Reel/Frame 018932/0795 →
Assignment of Assignor's Interest Oct 17, 2007
From: WELLER, DWIGHT D.; GELLER, BRUCE L.; IVERSEN, PATRICK L.; TILLEY, LUCAS D.
To: AVI BIOPHARMA, INC.
Reel/Frame 019975/0702 →
Assignment of Assignor's Interest Jun 8, 2009
From: FOX, CHRISTINA MARY JOSEPHINE; WELLER, DWIGHT D.
To: AVI BIOPHARMA, INC.
Reel/Frame 022794/0309 →
Assignment of Assignor's Interest Dec 22, 2016
From: IVERSEN, PATRICK L.; MOULTON, HONG M.; NELSON, MICHELLE H.; KROEKER, ANDREW D.
To: AVI BIOPHARMA, INC.
Reel/Frame 040747/0005 →
Security Interest May 7, 2025
From: SAREPTA THERAPEUTICS, INC.
To: JPMORGAN CHASE BANK, N.A. AS ADMINISTRATIVE AGENT
Reel/Frame 071218/0445 →